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Abstract: 
Background & Aims: Nutrition screening and assessment enable early identification of 
malnourished people and those at risk of malnutrition. Appropriate assessment tools 
assist with informing and monitoring nutrition interventions. Tool choice needs to be 
appropriate to the population and setting.  
Methods: Community-dwelling people with Parkinson’s disease (>18 years) were 
recruited. Body mass index (BMI) was calculated from weight and height. Participants 
were classified as underweight according to World Health Organisation (WHO) 
(≤18.5kg/m2) and age specific (<65 years,≤18.5kg/m2; ≥65 years,≤23.5kg/m2) cut-offs. 
The Mini-Nutritional Assessment (MNA) screening (MNA-SF) and total assessment 
scores were calculated. The Patient-Generated Subjective Global Assessment (PG-
SGA), including the Subjective Global Assessment (SGA), was performed. Sensitivity, 
specificity, positive predictive value, negative predictive value and weighted kappa 
statistic of each of the above compared to SGA were determined. 
Results: Median age of the 125 participants was 70.0(35-92) years.  Age-specific BMI 
(Sn 68.4%, Sp 84.0%) performed better than WHO (Sn 15.8%, Sp 99.1%) categories. 
MNA-SF performed better (Sn 94.7%, Sp 78.3%) than both BMI categorisations for 
screening purposes. MNA had higher specificity but lower sensitivity than PG-SGA 
(MNA Sn 84.2%, Sp 87.7%; PG-SGA Sn 100.0%, Sp 69.8%).  
Conclusions: BMI lacks sensitivity to identify malnourished people with Parkinson’s 
disease and should be used with caution. The MNA-SF may be a better screening tool in 
people with Parkinson’s disease. The PG-SGA performed well and may assist with 
informing and monitoring nutrition interventions. Further research should be conducted 
to validate screening and assessment tools in Parkinson’s disease. 
  
Introduction: 
The negative outcomes of protein-energy malnutrition have been well-documented, and 
it is also well-known that malnutrition is an under-recognised problem throughout the 
healthcare system.1 To identify and address malnutrition early, appropriate screening 
and assessment tools and processes are necessary.  
Nutrition screening aims to identify patients that may require further nutrition assessment 
and intervention due to malnutrition risk. Screening tools do not require nutrition 
expertise and therefore can be performed by any health professional. Nutrition 
assessment is a more comprehensive process requiring information (diet history/energy 
intake, recent weight changes, physical exam, functional status, medical history1) that 
can aid in the identification of intervention goals and strategies and therefore requires 
expertise and training.2,3 
It has been suggested that people with Parkinson’s disease (PWP) may be at higher risk 
of malnutrition despite a lack of consensus about the extent of malnutrition in PWP.4 The 
inability to reach an agreement on the prevalence could potentially be due to the tool 
used to assess nutritional status. Body mass index (BMI) has traditionally been used in 
PWP4,5, but more recently the Mini-Nutritional Assessment (MNA)6,7 and the Subjective 
Global Assessment (SGA)8 have also been used.  
The MNA and SGA are valid methods for nutrition assessment of malnutrition in the 
elderly (>65 years) in the community (DAA guidelines). Both the SGA and the scored 
Patient-Generated Subjective Global Assessment (PG-SGA), which provides a score as 
well as a global assessment are valid for assessing malnutrition in all adults in the acute 
setting (DAA guidelines). The widespread validity of the SGA and increasingly the 
scored version, for many diseases in the acute setting across all ages and in the 
community for the elderly, suggests these tools are suitable for assessment of 
malnutrition for those in the community with PD.  The PG-SGA specifically identifies 
nutrition impact symptoms, which are known to influence nutritional status in other 
disease states, but which are also particularly common in Parkinson’s disease (PD). PD 
can be diagnosed as early as the third decade, and there is considerable symptomatic 
intra- and inter-individual variability. . The nutrition assessment tool used in this 
population therefore needs to take into account the presence and diversity of these 
symptoms across a wide age range. Therefore, the PG-SGA, as an assessment tool, 
may be more appropriate and provide more guidance for nutrition interventions than the 
MNA.  
This paper aims to compare and evaluate the use of BMI and the MNA short-form (MNA-
SF) for nutrition screening and the use of the MNA and PG-SGA to assess nutritional 
status in community-dwelling PWP.  
  
Materials and Methods: 
Recruitment: 
Community-dwelling PWP, aged >18 years were recruited. Recruitment methods have 
been reported previously.9 Informed written consent was obtained as per protocol 
approved by the Queensland University of Technology Human Research Ethics 
Committee.  
Nutrition screening and assessment: 
Body weight was measured to the nearest 0.1kg (Tanita HD-316, Japan) in light clothing, 
without shoes, while fasted. Ten participants had visible peripheral oedema but no 
adjustments were made to body weight. For those participants able to stand 
independently, height was measured to the nearest 0.1cm, without shoes. For those 
unable to stand independently or with marked stooped posture, knee height was 
measured to the nearest 0.1cm using a knee caliper on the left leg with the knee and 
ankle at a 90° angle. The equations used were: (men) height (cm) = 78.31 + (1.94 x 
knee height) - (0.14 x age); (women) height (cm) = 82.21 + (1.85 x knee height) - (0.21 x 
age).10 BMI was calculated (body weight(kg)/(height in metres)2) and used as a nutrition 
screening tool.  
The MNA was specifically developed for use as both a screening and an assessment 
tool in frail elderly people.11 It is short, requires little training and has been widely used. 
The full assessment includes 18 questions with a total possible score of 30 points 
(<17=malnourished, 17-23.5=at risk of malnutrition, ≥24=well-nourished). The MNA sub-
scores are as follows: Anthropometry assessment: sum of items B(weight loss), F(BMI), 
Q(mid-arm circumference), R(calf circumference); Self assessment: sum of items O(self-
view of nutritional status), P(self-view of health status); Dietary assessment: sum of 
items A(appetite/food intake), J(meals/day), K(protein intake), L(fruit & vegetable intake), 
M(fluid intake), N(ability to self-feed); General assessment: sum of items C(mobility), 
D(recent illness or stress), E(dementia/depression), G(living situation), H(medication), 
I(pressure sores/skin ulcers).12 The revised screening form (MNA-SF), includes 6 of the 
18 questions (appetite, weight loss, mobility, recent illness/stress, dementia/depression, 
BMI or calf circumference) for a total of 14 points (≤7=malnourished, 8-11=risk of 
malnutrition, 12-14=well-nourished).13 Both the MNA and MNA-SF are considered valid 
tools in the community for older adults.3 
The Subjective Global Assessment (SGA)14 is also a valid and reliable tool in the 
community setting for assessing nutritional status in older adults3 and has been widely 
used in other populations, such as surgical patients, oncology and chronic kidney 
disease.15 It has been recommended as the tool to use for further nutrition assessment 
when screening identifies someone at risk of malnutrition.16 Because it has been shown 
to be a robust tool, it is considered the ‘gold standard’ by which to assess screening and 
assessment tools.17 It consists of a medical history (recent changes in weight, 
gastrointestinal symptoms, food intake, functional impairment) and physical examination 
of fat and muscle stores. The assessment results in a global rating of nutritional status: 
SGA-A (well nourished), SGA-B (moderately malnourished) or SGA-C (severely 
malnourished). 
The scored Patient-Generated Subjective Global Assessment (PG-SGA)18 is an 
adaptation of the SGA developed specifically for use in oncology with additional 
information about the presence of nutrition impact symptoms. It is comprised of 4 
worksheets that provide a total PG-SGA score (higher score indicates poorer nutritional 
status). Worksheet 1, which is completed by the participant, provides a score for recent 
changes in weight (Box 1), food intake (Box 2), nutrition impact symptoms (Box 3) and 
functional capacity (Box 4). Worksheet 2 provides a score for the presence of disease. 
Worksheet 3 provides a score for components of metabolic stress, and finally Worksheet 
4 consists of the physical examination score. Worksheets 2, 3 and 4 are completed by a 
trained health professional. 
Nutrition triage categories provide guidance as to the level of nutrition intervention 
required (0-1 no intervention required; 2-3 patient and family education; 4-8 symptom 
management and nutrition intervention required; ≥9 urgent need for nutrition 
intervention). The continuous score allows for changes in nutritional status in response 
to interventions to be monitored over time.17 Since its development, the scored PG-SGA 
has also been used extensively in different populations, including stroke, chronic kidney 
disease, oncology and the elderly.19–23  
The scored PG-SGA and the MNA were performed by the same dietitian according to 
the instructions.  
Statistical analysis: 
The World Health Organisation (WHO) cut-offs were used to place all participants into 2 
categories: at risk of malnutrition (BMI<18.5kg/m2) or well-nourished (BMI≥18.5kg/m2). 
Separately, participants aged <65 were categorised using WHO categorisations and 
participants aged ≥65 years were placed in the same 2 categories using age-adjusted 
cut-offs to account for the different effects of BMI on mortality in older adults: at risk of 
malnutrition (BMI<23.5kg/m2) or well-nourished (BMI ≥23.5).24  
The malnourished and at risk of malnutrition categories for the MNA and the MNA-SF 
were combined for each. This resulted in 2 classifications for each: well-nourished 
(MNA-1 and MNASF-1) and at risk of malnutrition/malnourished (MNA-2 and MNASF-2). 
PG-SGA scores ≥4 points indicated a need for nutrition intervention (malnourished), 
scores <4 points indicated no need for nutrition intervention (well-nourished). 
Differences between dichotomous categories for each screening/assessment method 
were assessed for PG-SGA scores and MNA scores. Age, BMI, PG-SGA and MNA 
scores were not normally distributed. Therefore, non-parametric Mann-Whitney tests 
were used to compare values. Fisher’s exact tests were conducted to examine 
differences in categorical variables. A weighted kappa statistic was used to determine 
agreement between each of the screening/assessment methods and SGA(A, B) with 
weighting towards a higher sensitivity and the predictive value of a negative test and 
jackknife estimates of standard error.25 The levels of agreement were determined using 
the following: slight 0.01 – 0.20, fair 0.21 to 0.40, moderate 0.41 to 0.60, substantial 0.61 
to 0.80, almost perfect 0.81 – 1.0.26 Sensitivity and specificity analyses of each of the 
methods were carried out using contingency tables compared to SGA results. Receiver 
operating curve (ROC) analysis was conducted to find the PG-SGA value at the highest 
levels of sensitivity and specificity for SGA categorisation.  
Statistical analysis was completed using SPSS Version 19 (SPSS Inc., Chicago, IL, 
USA). Statistical significance was set at p<0.05.   
Results: 
One hundred twenty five community dwelling adults aged ≥18 years (74 M, 51 F) agreed 
to participate. Median age was 70.0 years (range: 35-92 years).  
Using the WHO and age-specific BMI categories, 4(3%) and 30(29%) were considered 
at risk of malnutrition. The MNA-SF meanwhile resulted in 3(2%) malnourished and 
38(30%) at risk of malnutrition. The MNA identified 2(2%) as malnourished with an 
additional 27(22%) at risk of malnutrition. Nineteen (15%) were classified as SGA-B and 
none classified as SGA-C. The scored PG-SGA resulted in 51 (41%) classified as 
malnourished. Table 1 outlines the characteristics of each categorisation 
(malnourished/at risk, well-nourished) according to each of the screening and 
assessment tools.  
When comparing results for the MNA sub-scores and the PG-SGA worksheets, WHO 
BMI categories detected differences in MNA anthropometric measures, 
U=479.0,z=3.69,p=.000, MNA self-assessment, U=417.0,z=2.55,p=.011, and PG-SGA 
weight history, U=78.0,z=-3.35,p=.001. The age-specific BMI categories detected 
differences in MNA anthropometric sub-score, U=2487.0,z=6.82,p=.000, MNA self-
assessment sub-score, U=1804.0,z=2.28,p=.023, PG-SGA Worksheet 1, Box 1 (weight 
history), U=1091.0,z=-2.82,p=.005, Worksheet 1, Box 3 (nutrition impact symptoms), 
U=1074.5,z=-2.38,p=.017, Worksheet 2 (presence of disease) U=1001.0,z=-
3.10,p=.002, and Worksheet 4 (physical exam), U=655.0,z=-5.31,p=.000. The MNA, 
SGA and PG-SGA all detected significant differences across all MNA and PG-SGA sub-
scores, except PG-SGA Worksheet 2 (presence of disease) or Worksheet 3 (metabolic 
stress) (MNA categories: MNA anthropometric sub-score, U=2337.5,z=6.14,p=.000, self-
assessment sub-score, U=2478.5,z=6.60,p=.000, dietary sub-score, 
U=2276.0,z=5.36,p=.000, general sub-score, U=1910.0,z=3.14,p=.002, PG-SGA 
Worksheet 1, U=536.5,z=-5.10,p=.000, Worksheet 4 (physical exam), U=637.0,z=-
5.27,p=.000; SGA categories: MNA anthropometric sub-score, U=159.0,z=-6.48,p=.000, 
self-assessment sub-score, U=469.5,z=-3.84,p=.000, dietary sub-score, U=394.0,z=-
4.37,p=.000, general sub-score, U=724.0,z=-2.01,p=.044, PG-SGA Worksheet 1, 
U=1683.5,z=6.78,p=.000, Worksheet 4 (physical exam), U=1783.0,z=-6.37,p=.000; PG-
SGA categories: MNA anthropometric sub-score, U=2539.5,z=3.64,p=.000, self-
assessment sub-score, U=2708.0,z=4.28,p=.000, dietary sub-score, 
U=2920.5,z=5.38,p=.000, general sub-score, U=2399.5,z=2.66,p=.008, PG-SGA 
Worksheet 1, U=1291.5,z=-4.36,p=.000, Worksheet 4 (physical exam), U=1203.0,z=-
4.10,p=.000). 
The concurrent validity for each of the screening and assessment tools is outlined in 
Table 2. In the screening tools, the MNA-SF had the best agreement with SGA 
(sensitivity 94.7%, specificity 78.3%, kw=0.92). The WHO BMI categories had poorer 
agreement with SGA than did the age-specific categories  (WHO kw =0.13; age-specific 
kw =0.58). However, the sensitivity was poor in both (WHO 15.8%, age-specific 68.4%). 
For assessment, the PG-SGA had better agreement (sensitivity 100.0%, specificity 
69.8%, kw =1.0) than the MNA.(sensitivity 84.2%, specificity 87.7%, kw=0.79) 
The ROC analysis of the PG-SGA score resulted in a significant area under the curve 
(AUC) value (0.91, p=.000) and a PG-SGA score of 5 for the combined highest values of 
sensitivity (94.7%) and specificity (83.0%) for SGA classification.  
  
Discussion: 
The Nutrition Care Process highlights the importance of nutrition screening and 
assessment for providing safe and effective quality nutrition care.27 This is especially 
true in a population where malnutrition is a concern, such as Parkinson’s disease.9 In the 
absence of objective validation studies, the current study provides guidance about the 
appropriate tools for use in the screening and assessment of people with PD. The 
current sample includes adults with PD of ages ranging from 35 to 92 years, which 
reflects the wider PD population. 
Comparison of screening tools 
Nutrition screening is an important first step to identify people who may be at nutritional 
risk and would benefit therefore from further assessment and interventions for 
improvements in nutritional status. As a measure that is well-recognised, easy to use 
and requiring little training, BMI is often preferred as a screening tool. While the WHO 
BMI categories are widely used across all age groups, it has been suggested that in 
older age, the BMI range that results in a lower risk of mortality is higher than that of 
younger people.24 In the current study, BMI, categorised according to WHO standards, 
had a very poor sensitivity (15.8%) while age-specific BMI categories performed better 
but still only moderately (sensitivity 68.4%) compared to the SGA. This is to be expected 
as BMI is not an adequate measure of nutritional status on its own due its static nature 
and inability to detect small but clinically significant changes in weight loss. WHO BMI 
categories also failed to distinguish differences in food intake and loss of lean and fat 
body mass, important components of malnutrition. Given that the age-specific BMI 
categories performed better than the WHO categories and were able to distinguish 
between those with more severe nutrition impact symptoms and decreased fat stores 
and muscle status, they might be a more appropriate screening choice. However, the 
age-specific categories may still result in substantial misclassification of malnourished 
individuals, and they should therefore be used with caution. This is particularly true given 
that it is difficult to obtain accurate measurements of weight and height in practice in the 
community,13,22 not only because of the equipment required but also because of the 
presence of oedema and the need to use estimated height in some. Side effects of PD 
medication can be peripheral oedema, and changes in stature are also common due to 
the stooped posture associated with PD. 
The MNA-SF performed well when compared with the SGA meeting the definition of a 
good screening tool set forth previously.28 The inclusion of questions regarding appetite, 
recent weight loss, mobility and anthropometry is a strength of the MNA-SF. It is also 
quick, easy to use and can be completed by any health professional. With the recent 
revised version, BMI is not required making it easier to complete when height and weight 
measurements may be difficult to obtain. The MNA-SF has only been validated for use in 
adults over the age of 65 years, however. The current study included participants 
younger than 65 years, to reflect the general PD population. The performance of the 
MNA-SF was superior to that of the other screening tools in the current sample, but 
further objective validation should be performed in adults of all ages. 
The nutrition screening tools covered here do not represent the wide range of commonly 
used tools that are available, such as the Malnutrition Screening Tool (MST) and the 
Malnutrition Universal Screening Tool (MUST). Other tools may be appropriate for use in 
PWP, and future research could identify which is the most valid and reliable in this 
population.  
Comparison of nutrition assessment tools 
Similarly to other studies using the MNA in PWP,6,7 24% were classified as 
malnourished/at risk of malnutrition in the current study. Comparatively, 15% were 
classified as moderately malnourished (SGA-B) using SGA. The use of the PG-SGA with 
cut-offs identifying those at need of intervention (≥4) established for oncology patients 
also resulted in 15% malnourished. 
The MNA exhibited good sensitivity (84.2%) and specificity (87.7%) with the SGA when 
the malnourished and at risk of malnutrition classifications were combined. Considering 
the classifications separately, only 2% of the sample was identified as malnourished with 
the MNA.  
It has previously been suggested that the MNA lacks both specificity29 and sensitivity30 
for identifying nutritional status when the three separate classifications are used. The 
MNA malnourished (<17 points) category may be useful to identify those who are 
severely malnourished but not for those who are moderately malnourished,31 and the 
MNA at risk of malnutrition (17-24 points) classification may not adequately differentiate 
between those who are moderately malnourished and those who are at risk of 
malnutrition. In this way, the MNA may act more as a screening than an assessment tool 
in the community. This is supported by previous recommendations to use the MNA as a 
screening tool and the SGA as the tool for further nutrition assessment.16 In this case, 
the MNA-SF may be a more appropriate screening tool in PD due to its brevity and 
superior performance over the MNA.  
The scored PG-SGA, used as it was developed for oncology patients, performed the 
best when compared to the SGA. This is not surprising given that the SGA is a 
component of the PG-SGA. In fact, the score is not meant to be used alone for nutrition 
diagnosis but in concert with the SGA classification. A recognised limitation of the SGA 
is its inability to detect small but clinically significant changes in nutrition status, and it is 
more suited for identifying established malnutrition. The PG-SGA score can 
independently provide an indicator of nutritional risk as well as act as a sensitive 
measure of nutritional status change in response to interventions. 
Another advantage of the scored PG-SGA is that it captures the majority of the 
components required for malnutrition diagnosis set forth in a recent consensus 
statement.1 The PG-SGA can also be applied across all ages and relies on a visual 
examination of fat and muscle status that is independent of total body mass, important in 
a society whose body mass is becoming increasingly larger. The PG-SGA facilitates the 
collection of data regarding the influence of nutrition impact symptoms, such as poor 
appetite, nausea, constipation, problems swallowing, early satiety and depression, on 
intake. These symptoms commonly occur in Parkinson’s disease and can provide 
information on which to base an intervention plan (medical and/or nutrition) and its 
subsequent monitoring.18,20,22 Individualisation of interventions, which is important given 
the heterogeneity of symptoms for each PWP, can occur based on these symptoms.  
Disadvantages of the scored PG-SGA include the need for training and the potential 
influence of the clinicians’ experience with the tool on the outcome. Therefore, its use on 
a wider scale may be limited, but with the use of an appropriate screening tool, further 
assessment and intervention, as necessary, can be completed by someone trained and 
experienced with the use of the scored PG-SGA.  
Because it was developed for oncology patients, it may not perfectly suit other 
populations. In this sample of community-dwelling adults with a chronic disease, the 
worksheets capturing details of acute illness (Worksheets 2 and 3) did not significantly 
contribute to the distinction between nutritional states. Therefore, different cut-offs may 
be required for appropriate triaging and prioritisation of nutrition interventions in PWP. 
The modified cut-off of 5 resulted in better specificity while retaining excellent sensitivity. 
Therefore, it might be more appropriate for the identification of PWP requiring 
intervention. 
Limitations 
Limitations of the current study include the lack of an objective gold standard measure of 
nutritional status with which to compare each of the tools. Instead, the SGA acted as the 
gold standard which may influence the results given its subjective nature. Additionally, 
the SGA is part of the PG-SGA assessment, and this may have influenced the 
comparison of results with the SGA. Future research should perform an objective 
validation of the tools along with a prospective analysis of each tool’s ability to predict 
poor outcomes in PWP. Following on from this, it is important to determine if appropriate 
screening, assessment and interventions decrease the prevalence of malnutrition in this 
group.  
This was not a comprehensive analysis of the available nutrition screening and 
assessment tools. The focus was on tools that have been used previously in PWP, 
regardless of the age range for which the tool was validated. Therefore, a more 
appropriate tool for use in this population may not have been identified. The sample 
studied may limit the generalisability of the results to other settings, such as the acute 
care setting where the acute condition may take precedence over the more established 
symptoms in PD. 
Given the poor outcomes, including mortality and morbidity, associated with malnutrition, 
the emphasis is on nutrition screening and assessment tools with a high sensitivity. This 
may result in more false positives and perhaps burden already scarce resources. 
However, consideration must be given to the fact that the result of a false positive is less 
harmful than a false negative.25   
While the length of time to administer each tool was not recorded in the current study, 
this information may prove useful when determining the practicality of a tool in a specific 
setting, given relative specificity and sensitivity.  
Conclusion 
Nutrition assessment can be time-consuming and burdensome. Therefore, the use of a 
screening tool can be a quick way to identify people at risk. The most important 
consideration is to use a tool that is appropriate to the setting. The MNA-SF performed 
well as a screening tool in this sample of PWP.   
It is also important to select assessment tools that are appropriate to the setting, the 
population, will provide information on which to base interventions and allow for 
monitoring of those interventions. The scored PG-SGA performed well for nutrition 
assessment. In cases where only a geriatric population is included, the MNA may be 
appropriate to the setting and may be more appropriate in terms of training and staff 
burden. Clinically, the PG-SGA may be useful to inform and monitor nutrition and 
medical interventions aimed at improving nutritional status in PWP. Further research 
should be conducted to validate available screening and assessment tools for use in 
PWP. 
  
Acknowledgements 
JS conceived of the study, carried out the study, performed the statistical analysis and 
drafted the manuscript. SA participated in the design of the study and assisted with the 
statistical analysis and revision of the manuscript. GM assisted with the statistical 
analysis and revision of the manuscript. PA participated in study coordination and 
assisted with revision of the manuscript. GK participated in the design of the study and 
assisted with revision of the manuscript. All authors read and approved the final 
manuscript.  
Parkinson’s Queensland, Inc. provided funding for the study but had no involvement in 
the study design, data collection, data analysis, writing of the manuscript or in the 
decision to submit the manuscript for publication. GK and PA participate in the 
committee of Parkinson’s Queensland, Inc.  
There are no conflicts of interest to declare.
Table 1: Characteristics of malnourished participants presented as mean(s.d) and 
range for normally distributed variables or as median and range for non-normally 
distributed variables	
 SGA-B  (n=19) 
MNA at risk of 
malnutrition + 
malnourished  
(MNA-2+3) 
(n=29) 
Age (years) 74.0 (61.0 – 87.0) 
69.0 
(35.0 – 87.0) 
Gender 9 females 10 males 
13 females 
16 males 
BMI (kg/m2) 
20.0 
(17.7 - 33.2) 
21.6 
(17.0 - 39.5) 
MAC (cm) 25.9(4.0) (21.0 - 35.0) 
27.4(5.3) 
(21.0 - 40.5) 
Calf circumference (cm) 32.8(3.0) (28.0 - 39.0) 
35.1(4.9) 
(28.0 - 46.0) 
Waist circumference 
(cm) 
84.5(13.3) 
(65.5 - 116.0) 
91.5(18.1) 
(65.5 - 124.0) 
   
MNA Score 21.0 (15.5 - 26.0) 
22.0 
(15.5 - 23.5) 
Anthropometry sub-
score 
5.0 
(1.0 – 7.0) 
5.0 
(1.0 – 8.0) 
Self-assessment sub-
score 
2.0 
(0 – 4.0) 
2.0 
(0 – 3.0) 
Dietary assessment sub-
score 
7.5 
(6.0 – 9.0) 
7.5 
(6.0 – 9.0) 
General assessment 
sub-score 
7.0 
(5.0 – 8.0) 
7.0 
(5.0 – 9.0) 
   
PG-SGA Score 8 (4 - 18) 
8 
(1 - 15) 
Wksht 1: Nutrition Hx 6  (1 – 15) 
5 
(0 – 15) 
Wksht 1 Box 1: Weight 
Hx 
1 
(0 – 4) 
1 
(0 – 4) 
Wksht 1 Box 2:  
Food intake 
1 
(0 – 1) 
1 
(0 – 2) 
Wksht 1 Box 3: 
Symptoms 
3 
(0 – 9) 
2 
(0 – 4, 12) 
Wksht 1 Box 4: Function 1 1 
(0 – 3) (0 – 3) 
Wksht 2: Presence of 
disease 
1 
(0 – 1) 
1 
(0 – 2) 
Wksht 3: Metabolic 
stress 
0 
(0) 
0 
(0) 
Wksht 4: Physical exam 1 (0 – 2) 
1 
(0 – 2) 
PG-SGA score ≥9 9 (47%) 9 (47%) 
Abbreviations: BMI=body mass index; Hx = history; MAC=mid-arm 
circumference; MNA=Mini-Nutritional Assessment; PG-SGA=Patient-Generated 
Subjective Global Assessment; SGA= Subjective Global Assessment; Wksht = 
Worksheet 
Table 2: Cross-tabulation of participants in each category of SGA and MNA	
 
Well-nourished (MNA-1) 
(n=96) 
Malnourished/at risk of 
malnutrition (MNA-2+3) 
(n=29) 
SGA-A 
(n=106) 
93 13  
SGA-B 
(n=19) 
3 16* 
*MNA 2+3 identified 84% of those at risk using the SGA. SGA-B identified 55% of 
those at risk using the MNA. 
 
 
 Table 3: MNA sub-score and PG-SGA Worksheet differences between the 
groupings to explore the discrepancies between the MNA and SGA 
categorisations presented as median values and ranges 
 MNA-2 + SGA A (n=13) 
MNA-2+3 + SGA 
B (n=16) 
MNA-1 + SGA B 
(n=3) 
MNA Score 23.0* (21.0 - 23.5) 
20.0*† 
(15.5 - 23) 
25.0† 
(24.5 - 26.0) 
Anthropometry sub-
score 
7.0* 
(4.0 – 8.0) 
5.0*† 
(1.0 – 7.0) 
7.0† 
(6.0 – 7.0) 
Self-assessment 
sub-score 
2.0 
(0 – 2.0) 
2.0† 
(0 – 3.0) 
4.0† 
(2.0 – 4.0) 
Dietary assessment 
sub-score 
7.5 
(6.0 – 9.0) 
7.5 
(6.0 – 9.0) 
7.0 
(7.0 – 8.5) 
General assessment 
sub-score 
7.0 
(5.0 – 9.0) 
7.0 
(5.0 – 8.0) 
8.0 
(7.0 – 8.0) 
PG-SGA Score 5* (1-15) 
8* 
(3-18) 
10 
(6-11) 
Wksht 1: Nutrition Hx 2* (0-14) 
6* 
(4-12) 
8 
(5-9) 
Wksht 1 Box 1: 
Weight Hx 
0* 
(0-2) 
1* 
(0-4) 
1 
(1) 
Wksht  1 Box 2: Food 
intake 
0 
(0-2) 
1 
(0-1) 
0 
(0-1) 
Wksht 1 Box 3: 
Symptoms 
0 
(0-4, 12) 
3 
(0-9) 
6 
(3-7) 
Wksht 1 Box 4: 
Function 
1 
(0-2) 
1 
(0-3) 
1 
(0-1) 
Wksht 2: Presence of 
disease 
1 
(0-2) 
1 
(0-1) 
1 
(1) 
Wksht 3: Metabolic 
stress 
0 
(0) 
0 
(0) 
0 
(0) 
Wksht 4: Physical 
exam 
0* 
(0-2) 
1* 
(0-2) 
1 
(0-1) 
PG-SGA Triage (0-1) 1 (8%) 0 0 
PG-SGA Triage (2-3) 3 (23%) 1 (6%) 0 
PG-SGA Triage (4-8) 7 (54%) 8 (50%) 1 (33%) 
PG-SGA Triage (≥9) 2 (15%) 7 (44%) 2 (67%) 
Abbreviations: Hx = history; MNA=Mini-Nutritional Assessment; PG-
SGA=Patient-Generated Subjective Global Assessment; SGA= Subjective Global 
Assessment; Wksht = Worksheet 
*Significant difference between groups, p<.05 
†Significant difference between groups, p<.05 
	
Comment [JMS1]: Would	this	table	
benefit	from	including	the	well‐
nourished	(MNA‐1		+	SGA‐A)?	
Table 4: Questions/worksheets of the PG-SGA and MNA which are 
significant (p<.05) predictors of SGA category and MNA category and 
corresponding odds ratios 
 SGA category  
(SGA-B) 
MNA category 
(MNA-2+3) 
MNA A: Food intake 0.04 (0.01 – 0.19) 0.13 (0.02 – 0.67) 
MNA B: Weight loss 0.46 (0.22 – 0.95) 0.24 (0.11 – 0.54) 
MNA D: Stress or acute 
disease 
- 0.23 (0.09 – 0.57) 
MNA F: BMI 0.19 (0.08 – 0.44) 0.18 (0.07 – 0.51) 
MNA N: Feeding - 0.15 (0.03 – 0.69) 
MNA O: Self-view 
nutritional status 
- 0.09 (0.02 – 0.41) 
   
PG-SGA Worksheet 1, 
Box 1: Weight History 
21.67 (2.82 – 
166.23) 
6.74 (2.09 – 21.68) 
PG-SGA Worksheet 1, 
Box 2: Food intake 
7.41 (1.75 – 31.37) 2.74 (1.32 – 5.73) 
PG-SGA Worksheet 1, 
Box 3: Symptoms 
1.59 (1.13 – 2.24) - 
PG-SGA Worksheet 4: 
Physical examination 
57.74 (5.04 – 
661.15) 
7.39 (2.59 (21.13) 
Abbreviations: MNA=Mini-Nutritional Assessment; PG-SGA=Patient-Generated 
Subjective Global Assessment; SGA= Subjective Global Assessment 
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